Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2023 |
| Outros Autores: | , , , , , |
| Tipo de documento: | Artigo de conferência |
| Idioma: | por |
| Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
| Texto Completo: | https://www.arca.fiocruz.br/handle/icict/58056 |
Resumo: | Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz. Apresentador do material: Gabriel Mustafá Misirli. Tipo de material apresentado: Pôster. |
| id |
CRUZ_f0577954ff488422b66d13a35d5116c8 |
|---|---|
| oai_identifier_str |
oai:www.arca.fiocruz.br:icict/58056 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Misirli, Gabriel MustafáFontao, Ana Paula Gregorio AlvesCastro, Renata Ribeiro deAbrantes, Shirley de Mello PereiraSampaio, André Luiz FrancoSilva, Edimilson Domingos daMissailidis, Sotiris2023-04-28T13:54:49Z2023-04-28T13:54:49Z2023MISIRLI, G. M. et al. Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICALS, 7., 2023, Rio de Janeiro. Annals of the Symposium: building pathways to accelerated the development of the national tecnhnological innovation ecosystem. Rio de Janeiro: Instituto de Tecnologia em Imunobiológicos, 2023. p. 106.https://www.arca.fiocruz.br/handle/icict/5805610.35259/isi.2023_58056Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz. Apresentador do material: Gabriel Mustafá Misirli. Tipo de material apresentado: Pôster.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Fármacos - Farmanguinhos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Fármacos - Farmanguinhos. Rio de Janeiro, RJ, Brasil.Universidade Anhanguera de São Paulo. São Paulo, SP, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Fármacos - Farmanguinhos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.porAntitumoralCancernanopartícula de prataSilver nanoparticleAntitumoralCancerNeoplasiasEvaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cellsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/58056/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALAnais7thISI2023_106.pdfAnais7thISI2023_106.pdfapplication/pdf181052https://www.arca.fiocruz.br/bitstream/icict/58056/2/Anais7thISI2023_106.pdf860a20b04d9e58890cdcce5e0ff20441MD52icict/580562023-08-26 15:27:03.758oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-08-26T18:27:03Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.en_US.fl_str_mv |
Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells |
| title |
Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells |
| spellingShingle |
Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells Misirli, Gabriel Mustafá Antitumoral Cancer nanopartícula de prata Silver nanoparticle Antitumoral Cancer Neoplasias |
| title_short |
Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells |
| title_full |
Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells |
| title_fullStr |
Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells |
| title_full_unstemmed |
Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells |
| title_sort |
Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells |
| author |
Misirli, Gabriel Mustafá |
| author_facet |
Misirli, Gabriel Mustafá Fontao, Ana Paula Gregorio Alves Castro, Renata Ribeiro de Abrantes, Shirley de Mello Pereira Sampaio, André Luiz Franco Silva, Edimilson Domingos da Missailidis, Sotiris |
| author_role |
author |
| author2 |
Fontao, Ana Paula Gregorio Alves Castro, Renata Ribeiro de Abrantes, Shirley de Mello Pereira Sampaio, André Luiz Franco Silva, Edimilson Domingos da Missailidis, Sotiris |
| author2_role |
author author author author author author |
| dc.contributor.author.fl_str_mv |
Misirli, Gabriel Mustafá Fontao, Ana Paula Gregorio Alves Castro, Renata Ribeiro de Abrantes, Shirley de Mello Pereira Sampaio, André Luiz Franco Silva, Edimilson Domingos da Missailidis, Sotiris |
| dc.subject.other.en_US.fl_str_mv |
Antitumoral Cancer nanopartícula de prata |
| topic |
Antitumoral Cancer nanopartícula de prata Silver nanoparticle Antitumoral Cancer Neoplasias |
| dc.subject.en.en_US.fl_str_mv |
Silver nanoparticle Antitumoral Cancer |
| dc.subject.decs.en_US.fl_str_mv |
Neoplasias |
| description |
Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz. Apresentador do material: Gabriel Mustafá Misirli. Tipo de material apresentado: Pôster. |
| publishDate |
2023 |
| dc.date.accessioned.fl_str_mv |
2023-04-28T13:54:49Z |
| dc.date.available.fl_str_mv |
2023-04-28T13:54:49Z |
| dc.date.issued.fl_str_mv |
2023 |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/conferenceObject |
| format |
conferenceObject |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
MISIRLI, G. M. et al. Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICALS, 7., 2023, Rio de Janeiro. Annals of the Symposium: building pathways to accelerated the development of the national tecnhnological innovation ecosystem. Rio de Janeiro: Instituto de Tecnologia em Imunobiológicos, 2023. p. 106. |
| dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/58056 |
| dc.identifier.doi.none.fl_str_mv |
10.35259/isi.2023_58056 |
| identifier_str_mv |
MISIRLI, G. M. et al. Evaluation of anticancer activity of silver nanoparticles on human leukemia, breast cancer, and melanoma cells. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICALS, 7., 2023, Rio de Janeiro. Annals of the Symposium: building pathways to accelerated the development of the national tecnhnological innovation ecosystem. Rio de Janeiro: Instituto de Tecnologia em Imunobiológicos, 2023. p. 106. 10.35259/isi.2023_58056 |
| url |
https://www.arca.fiocruz.br/handle/icict/58056 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/58056/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/58056/2/Anais7thISI2023_106.pdf |
| bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 860a20b04d9e58890cdcce5e0ff20441 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1798324895496536064 |